Cantatore et al: Submucosal resection via a transanal approach for treatment of epithelial rectal tumors – a multicenter study
Veterinary Surgery 3, 2022

🔍 Key Findings

  • Submucosal resection via a transanal approach was associated with a low rate (1.1%) of major complications and prolonged survival across benign and malignant rectal tumors.
  • Overall recurrence rate was 21.5%, with higher recurrence in malignant tumors: 28.6% (carcinomas) and 30.4% (carcinoma in situ) vs. 13.6% (adenomas).
  • Complications (P = .032) and incomplete margins (P = .023) were independently associated with increased recurrence risk.
  • Recurrence was the only factor associated with increased risk of tumor-related death (P = .046).
  • Repeat submucosal resection was successful in 60% of dogs with recurrence, indicating feasibility of this as a salvage approach.
  • 1-, 2-, and 5-year survival rates for carcinomas were 95%, 89%, and 73%, though overall survival was significantly longer for benign tumors (P = .001).
  • Preoperative diagnostics (FNA, biopsy) were often inconsistent with final histopathology – only 64.3% biopsy agreement.
  • Presurgical imaging was not consistently performed, limiting accurate staging in many dogs.

Simini Surgery Review Podcast

How critical is this paper for crushing the Boards?

🚨 Must-know. I’d bet on seeing this.

📚 Useful background, not must-know.

💤 Skip it. Doubt it’ll ever show up.

Thanks for the feedback!
We'll keep fine-tuning the articles vault.
Oops — didn’t go through.
Mind trying that again?